[1]
|
H. Wisplinghoff, T. Bischoff, M. T. Sandra, et al., “Nosocomial Bloodstream Infections in US Hospitals: Analysis of 24,179 Cases from Prospective Nationwide Surveillance Study,” Clinical Infectious Diseases, Vol. 39, No. 3, 2004, pp. 309-317. doi:10.1086/421946
|
[2]
|
P. E. Fournier, “The Epidemiology and Control of Acinetobacter Baumannii in Health Care Facilities,” Clinical Infectious Diseases, Vol. 42, No. 5, 2006, pp. 692-699.
doi:10.1086/500202
|
[3]
|
C. Webster, K. Towner and H. Humphreys, “Survival of Acinetobacter on Three Clinically Related Inanimate Surfaces,” Infect Control Hosp Epidemiol, Vol. 21, No. 4, 2000, p. 246. doi:10.1086/503214
|
[4]
|
C. Wendt, B. Dietz, E. Dietz, et al., “Survival of Acinetobacter Baumannii on Dry Surfaces,” Journal of Clinical Microbiology, Vol. 35, No. 6, 1997, pp. 1394-1397.
|
[5]
|
B. Kurcik-Trajkovska, “Acinetobacter Spp.—A Serious Enemy Threatening Hospitals Worldwide,” Macedonian Journal of Medical Sciences, Vol. 2, No. 2, 2009.
|
[6]
|
J. M. Cisneros and J. Rodriguez-Bano, “Nosocomial Bacteremia due to Acinetobacter Baumannii: Epide- miology, Clinical Features, and Treatment,” Clinical Microbiology and Infection, Vol. 8, No. 7, 2002, pp. 687-693. doi:10.1046/j.1469-0691.2002.00487.x
|
[7]
|
E. Playford, J. Craig and J. Iredell, “Carbapenem- Resistant Acinetobacter Baumannii in Intensive Care Unit Patients: Risk Factors for Acquisition, Infection and Their Consequences,” The Journal of Hospital Infection, Vol. 65, No. 3, 2007, pp. 204-211. doi:10.1086/503214
|
[8]
|
P. A. Tiley and F. J. Roberts, “Bacteremia with Acinetobacter Species: Risk Factors and Prognosis in Different Clinical Settings,” Clinical Infectious Diseases, Vol. 18, No. 6, 1994, pp. 896-900. doi:10.1093/clinids/18.6.896
|
[9]
|
J. L. Garcia-Garmendia, C. Ortiz-Leyba, J. Garnacho- Montero, et al., “Risk Factors for Acinetobacter Baumannii Nosocomial Bacteremia in Critically Ill Patients: A Cohort Study,” Clinical Infectious Diseases, Vol. 33, No. 7, 2001, pp. 933-939. doi:10.1086/322584
|
[10]
|
M. J. Tong, “Septic Complications of War Wounds,” The Journal of the American Medical Association, Vol. 305, No. 24, 1972, pp. 1044-1047.
doi:10.1001/jama.219.8.1044
|
[11]
|
R. Martin, D. Martin and C. Levy, “Acinetobacter Osteomyelitis from a Hamster Bite,” The Pediatric Infectious Disease Journal, Vol. 7, No. 5, 1988, pp. 364-365.
doi:10.1097/00006454-198805000-00020
|
[12]
|
G. Volpin, N. Krivoy and H. Stein, “Acinetobacter Sp. Osteomyelitis of the Femur: A Late Sequel of Unrecognized Foreign Body Implantation,” Injury, Vol. 24, No. 5, 1993, pp. 345-346.
doi:10.1016/0020-1383(93)90063-C
|
[13]
|
J. Schafer and J. Mangino, “Multidrug Resistant Acinetobacter Osteomyelitis from Iraq,” Emerging Infectious Diseases, Vol. 14, No. 3, 2005, pp. 512-514.
doi:10.3201/eid1403.070128
|
[14]
|
K. Davis, K. Moran, C. McAllister and P. Gray, “Multi- drug-Resistant Acinetobacter Infections in Soldiers,” Emerging Infectious Diseases, Vol. 11, No. 8, 2005, pp. 1218-1224.
|
[15]
|
S. C. Collinet-Adler, C. A. Castro, C. G. Ledonio, et al., “Acinetobacter Baumannii Is Not Associated with Osteomyelitis in a Rat Model,” Clinical Orthopaedics and Related Research, Vol. 469, No. 1, 2011, pp. 274-282.
doi:10.1007/s11999-010-1488-0
|
[16]
|
D. P. Crane, K. Gromov, D. Li, et al., “Efficacy of Collistin-Impregnated Beads to Prevent Multidrug-Resistant A. Baumannii Implant-Associated Osteomyelitis,” Journal of Orthopaedic Research, Vol. 27, No. 8, 2009, pp. 1008-1005. doi:10.1002/jor.20847
|
[17]
|
J. T. Mader, M. Shirtliff and J. H. Calhoun, “The Host and the Skeletal Infection: Classification and Pathogenesis of Acute Bacterial Bone and Joint Sepsis,” Best Practice & Research Clinical Rheumatology, Vol. 13, No. 1, 1999, pp. 1-20. doi:10.1053/berh.1999.0003
|